![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Initial Evaluation of the Sofosbuvir Compassionate Use Program for Patients With Severe Recurrent HCV Following Liver Transplantation
|
|
|
Reported by Jules Levin
Presented at The Liver Meeting 2013: 64th Annual Meeting of the American Association for the Study of Liver Diseases, November 1-5, 2013, Washington, DC
Xavier Forns,1 Robert J. Fontana,2 Dilip Moonka,3 John G. McHutchison,4 William T. Symonds,4 Jill Denning,4 Lindsay McNair,4 Paul Chang,4 Valerie Kivett,4 Mitchell L. Shiffman,5 Michael Charlton6
1Liver Unit, Hospital Clinic, Barcelona, Spain; 2University of Michigan, Ann Arbor, MI; 3Henry Ford Health System, Detroit, MI; 4Gilead Sciences, Inc., Foster City, CA; 5Liver Institute of Virginia, Richmond, VA; 6Mayo Clinic, Rochester, MN
![AASLD1.gif](../images/110613/110613-4/AASLD1.gif)
![AASLD2.gif](../images/110613/110613-4/AASLD2.gif)
![AASLD3.gif](../images/110613/110613-4/AASLD3.gif)
![AASLD4.gif](../images/110613/110613-4/AASLD4.gif)
![AASLD5.gif](../images/110613/110613-4/AASLD5.gif)
![AASLD6.gif](../images/110613/110613-4/AASLD6.gif)
![AASLD7.gif](../images/110613/110613-4/AASLD7.gif)
![AASLD8.gif](../images/110613/110613-4/AASLD8.gif)
![AASLD9.gif](../images/110613/110613-4/AASLD9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|